News + Filings Transactions
|
Hamill Laura
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/08/2023 | Y-mAbs Therapeutics, Inc. | YMAB | Grant | | 14k | $8.13 | $113.4k | | 06/08/2023 |
| 06/08/2023 | Y-mAbs Therapeutics, Inc. | YMAB | Grant | Common Stock | 2.3k | $0.00 | $0 | | 06/08/2023 |
| 01/06/2023 | ANAPTYSBIO, INC | ANAB | Grant | Stock Option (right to buy) | 10.6k | $23.23 | $246.2k | | 01/06/2023 |
| 01/06/2023 | ANAPTYSBIO, INC | ANAB | Grant | Restricted Stock Unit | 3.9k | $0.00 | $0 | | 01/06/2023 |
| 07/15/2022 | Y-mAbs Therapeutics, Inc. | YMAB | Grant | | 16k | $16.64 | $266.2k | | 07/15/2022 |
| 06/08/2022 | PARDES BIOSCIENCES, INC. | | Grant | Stock Option (Right to Buy) | 37.5k | $5.21 | $195.4k | | 06/08/2022 |
| 02/10/2022 | ANAPTYSBIO, INC | ANAB | Grant | Stock Option (right to buy) | 9.2k | $30.44 | $280k | | 02/10/2022 |
| 12/23/2021 | PARDES BIOSCIENCES, INC. | | Grant | Stock Option (Right to Buy) | 75k | $9.80 | $735k | | 12/23/2021 |
| 11/19/2021 | ACCELERON PHARMA INC | XLRN | Disposition | Option to Purchase Common Stock | 941 | $115.53 | $108.7k | | 11/19/2021 |
| 11/19/2021 | ACCELERON PHARMA INC | XLRN | Disposition | Option to Purchase Common Stock | 9.3k | $101.88 | $951.5k | | 11/19/2021 |
| 11/19/2021 | ACCELERON PHARMA INC | XLRN | Other | Common Stock | 474 | $0.00 | $0 | | 11/19/2021 |
| 06/10/2021 | Y-mAbs Therapeutics, Inc. | YMAB | Grant | | 16k | $37.53 | $600.5k | | 06/10/2021 |
| 02/10/2021 | ANAPTYSBIO, INC | ANAB | Grant | Stock Option (right to buy) | 11k | $29.70 | $326.7k | | 02/10/2021 |
| 01/29/2021 | ACCELERON PHARMA INC | XLRN | Grant | Common Stock | 474 | $0.00 | $0 | | 01/29/2021 |
| 01/29/2021 | ACCELERON PHARMA INC | XLRN | Grant | Option to Purchase Common Stock | 941 | $115.53 | $108.7k | | 01/29/2021 |
| 09/15/2020 | ACCELERON PHARMA INC | XLRN | Grant | Option to Purchase Common Stock | 9.3k | $101.88 | $951.5k | | 09/15/2020 |
| 06/23/2020 | Y-mAbs Therapeutics, Inc. | YMAB | Grant | | 32k | $48.67 | $1.6M | | 06/23/2020 |
| 02/12/2020 | ANAPTYSBIO, INC | ANAB | Grant | Director Stock Option (Right to Buy) | 11k | $16.56 | $182.2k | | 02/12/2020 |
| 09/24/2019 | ANAPTYSBIO, INC | ANAB | Grant | Director Stock Option (Rigth to Buy) | 6k | $38.47 | $230.8k | | 09/24/2019 |
| 09/24/2019 | ANAPTYSBIO, INC | ANAB | Grant | Director Stock Option (Right to Buy) | 2.3k | $38.47 | $87.2k | | 09/24/2019 |
| 05/08/2019 | GILEAD SCIENCES, INC. | GILD | Grant | Common Stock | 9.8k | $0.00 | $0 | | 05/08/2019 |
| 05/08/2019 | GILEAD SCIENCES, INC. | GILD | Payment of Exercise | Common Stock | 3.5k | $66.07 | $231.2k | | 05/08/2019 |
| 02/06/2019 | GILEAD SCIENCES, INC. | GILD | Grant | Restricted Stock Unit | 13.6k | $0.00 | $0 | | 02/06/2019 |
| 02/06/2019 | GILEAD SCIENCES, INC. | GILD | Grant | Non-qualified Stock Option (Right to Buy) | 63.1k | $68.75 | $4.3M | | 02/06/2019 |
| 10/07/2018 | GILEAD SCIENCES, INC. | GILD | Grant | Non-qualified Stock Option (Right to Buy) | 87.7k | $76.24 | $6.7M | | 10/07/2018 |
| 10/07/2018 | GILEAD SCIENCES, INC. | GILD | Grant | Restricted Stock Unit | 32.8k | $0.00 | $0 | | 10/07/2018 |
|